Over the past 12 months, the application of generative AI (GenAI) in the Medical Instruments industry has moved from experimental to operational use, enhancing diagnostics, patient monitoring and intervention workflows. GenAI could transform health care through synthetic medical imaging, disease progression modeling sand drug molecule design with simulated effect, according to a 2025 U.S. National Science Foundation report. At the same time, regulatory bodies are adapting. The European Union AI Act (EU AI A ...